A New York private equity firm is launching an artificial intelligence-powered enterprise imaging platform, leaders announced Thursday.
Geneva PE, a “leading medtech-focused investment group,” is funding the startup of NXXIM (Nexus Enterprise Imaging). The platform is designed to integrate all available patient data including radiology images, pathology slides and lab results into a “unified, real-time diagnostic workspace.”
The investment group said NXXIM will combine advanced multimodal AI with “proprietary workflow orchestration.” This will allow for “rapid triage, precise decision support and significantly faster time to diagnosis” for radiologists, oncologists and other members of the care team.
“NXXIM represents a fundamental leap forward in diagnostic intelligence,” Joseph Bamberger, managing partner at Geneva Private Equity, said in a Dec. 11 announcement. “By uniting fragmented data silos with cutting-edge AI, we are empowering clinicians to make faster, more confident decisions that directly improve patient outcomes.”
Geneva PE said it has assembled a “world class leadership team” of industry veterans to oversee NXXIM but did not disclose any names. Those involved bring expertise in medical imaging, AI, data integration and healthcare IT. NXXIM is now working to develop initial clinical partnerships and plans to pilot its technology at select medical centers in 2026.
The announcement comes after GE HealthCare recently turned heads in the industry with the planned $2.3 billion purchase of Intelerad, another imaging platform provider.
